123 related articles for article (PubMed ID: 30221366)
1. Use of an at-home multilevel pregnancy test and an automated call-in system to follow-up the outcome of medical abortion.
Anger H; Dabash R; Peña M; Coutiño D; Bousiéguez M; Sanhueza P; Winikoff B
Int J Gynaecol Obstet; 2019 Jan; 144(1):97-102. PubMed ID: 30221366
[TBL] [Abstract][Full Text] [Related]
2. Randomized trial assessing home use of two pregnancy tests for determining early medical abortion outcomes at 3, 7 and 14days after mifepristone.
Blum J; Sheldon WR; Ngoc NT; Winikoff B; Nga NT; Martin R; Van Thanh L; Blumenthal PD
Contraception; 2016 Aug; 94(2):115-21. PubMed ID: 27067706
[TBL] [Abstract][Full Text] [Related]
3. Self-administered multi-level pregnancy tests in simplified follow-up of medical abortion in Tunisia.
Dabash R; Shochet T; Hajri S; Chelli H; Hassairi AE; Haleb D; Labassi H; Sfar E; Temimi F; Koenig L; Winikoff B
BMC Womens Health; 2016 Jul; 16():49. PubMed ID: 27475998
[TBL] [Abstract][Full Text] [Related]
4. Self-assessment of medical abortion outcome using symptoms and home pregnancy testing.
Raymond EG; Tan YL; Grant M; Benavides E; Reis M; Sacks DN; Hannum C; Frapp S; Weaver MA
Contraception; 2018 Apr; 97(4):324-328. PubMed ID: 29242085
[TBL] [Abstract][Full Text] [Related]
5. Serial multilevel urine pregnancy testing to assess medical abortion outcome: a meta-analysis.
Raymond EG; Shochet T; Blum J; Sheldon WR; Platais I; Bracken H; Dabash R; Weaver MA; Ngoc NTN; Blumenthal PD; Winikoff B
Contraception; 2017 May; 95(5):442-448. PubMed ID: 28041991
[TBL] [Abstract][Full Text] [Related]
6. Self-assessment of the outcome of early medical abortion versus clinic follow-up in India: a randomised, controlled, non-inferiority trial.
Iyengar K; Paul M; Iyengar SD; Klingberg-Allvin M; Essén B; Bring J; Soni S; Gemzell-Danielsson K
Lancet Glob Health; 2015 Sep; 3(9):e537-45. PubMed ID: 26275330
[TBL] [Abstract][Full Text] [Related]
7. Safety, efficacy and acceptability of outpatient mifepristone-misoprostol medical abortion through 70 days since last menstrual period in public sector facilities in Mexico City.
Sanhueza Smith P; Peña M; Dzuba IG; García Martinez ML; Aranguré Peraza AG; Bousiéguez M; Shochet T; Winikoff B
Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):75-82. PubMed ID: 25702071
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of telephone follow-up after medical abortion.
Perriera LK; Reeves MF; Chen BA; Hohmann HL; Hayes J; Creinin MD
Contraception; 2010 Feb; 81(2):143-9. PubMed ID: 20103453
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of self-performed urine pregnancy testing for follow-up after medical abortion.
Hassoun D; Périn I; Hiên H; Demars HH
Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():174-8. PubMed ID: 26773308
[TBL] [Abstract][Full Text] [Related]
10. Acceptability and feasibility of phone follow-up with a semiquantitative urine pregnancy test after medical abortion in Moldova and Uzbekistan.
Platais I; Tsereteli T; Comendant R; Kurbanbekova D; Winikoff B
Contraception; 2015 Feb; 91(2):178-83. PubMed ID: 25497383
[TBL] [Abstract][Full Text] [Related]
11. Follow-up strategies to confirm the success of medical abortion of pregnancies up to 10 weeks' gestation: a systematic review with meta-analyses.
Schmidt-Hansen M; Cameron S; Lohr PA; Hasler E
Am J Obstet Gynecol; 2020 Jun; 222(6):551-563.e13. PubMed ID: 31715147
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and acceptability of a mifepristone-misoprostol combined regimen for early induced abortion among women in Mexico City.
Peña M; Dzuba IG; Smith PS; Mendoza LJ; Bousiéguez M; Martínez ML; Polanco RR; Villalón AE; Winikoff B
Int J Gynaecol Obstet; 2014 Oct; 127(1):82-5. PubMed ID: 24957534
[TBL] [Abstract][Full Text] [Related]
13. Acceptability and feasibility of medical abortion with mifepristone and misoprostol in Nigeria.
Okonofua F; Shittu O; Shochet T; Diop A; Winikoff B
Int J Gynaecol Obstet; 2014 Apr; 125(1):49-52. PubMed ID: 24507887
[TBL] [Abstract][Full Text] [Related]
14. Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.
Kopp Kallner H; Fiala C; Stephansson O; Gemzell-Danielsson K
Hum Reprod; 2010 May; 25(5):1153-7. PubMed ID: 20172871
[TBL] [Abstract][Full Text] [Related]
15. [The efficacy and acceptability of mifepristone medical abortion with home administration misoprostol provided by private providers linked with the hospital: a prospective study of 433 patients].
Faucher P; Baunot N; Madelenat P
Gynecol Obstet Fertil; 2005 Apr; 33(4):220-7. PubMed ID: 15894206
[TBL] [Abstract][Full Text] [Related]
16. Acceptability and feasibility of the use of 400 μg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: evidence from Uzbekistan.
Raghavan S; Tsereteli T; Kamilov A; Kurbanbekova D; Yusupov D; Kasimova F; Jymagylova D; Winikoff B
Eur J Contracept Reprod Health Care; 2013 Apr; 18(2):104-11. PubMed ID: 23387475
[TBL] [Abstract][Full Text] [Related]
17. Acceptability and feasibility of outpatient medical abortion with mifepristone and misoprostol up to 70 days gestation in Singapore.
Tan YL; Singh K; Tan KH; Gosavi A; Koh D; Abbas D; Winikoff B
Eur J Obstet Gynecol Reprod Biol; 2018 Oct; 229():144-147. PubMed ID: 30179732
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous very low dose mifepristone and vaginal misoprostol for medical abortion.
Kapp N; Borgatta L; Ellis SC; Stubblefield P
Contraception; 2006 May; 73(5):525-7. PubMed ID: 16627039
[TBL] [Abstract][Full Text] [Related]
19. Simplified follow-up after medical abortion using a low-sensitivity urinary pregnancy test and a pictorial instruction sheet in Rajasthan, India--study protocol and intervention adaptation of a randomised control trial.
Paul M; Iyengar K; Iyengar S; Gemzell-Danielsson K; Essén B; Klingberg-Allvin M
BMC Womens Health; 2014 Aug; 14():98. PubMed ID: 25127545
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of Multilevel Pregnancy Tests for Telemedicine Abortion Service Follow-Up: A Pilot Study.
Chong E; Sheldon WR; Lopez-Green D; Gonzalez H C; Castillo BH; Ogando MG; Tuladhar N; Blum J
Int Perspect Sex Reprod Health; 2020 Dec; 46(Suppl 1):67-75. PubMed ID: 33326401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
